Biotechnology has been a standout performer in '20 as investors have focused on potential vaccines and treatments of Covid-19 rather than drug pricing. 
@cfraresearch @mattkrantz  $IBB $XBI $BBH $FBT $MRNA $GILD $AMGN $VRTX $CYTK #ETFs 
https://t.co/ZiMgmYqus6